These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 22424853

  • 1. Lower tissue factor inhibition in patients with ST segment elevation than in patients with non ST elevation acute myocardial infarction.
    Figueras J, Monasterio J, Lidón RM, Sambola A, Garcia-Dorado D.
    Thromb Res; 2012 Sep; 130(3):458-62. PubMed ID: 22424853
    [Abstract] [Full Text] [Related]

  • 2. Inflammatory and thrombotic markers in patients with ST-elevation myocardial infarction treated with thrombolysis and early PCI: a NORDISTEMI substudy.
    Halvorsen S, Seljeflot I, Weiss T, Bøhmer E, Arnesen H.
    Thromb Res; 2012 Sep; 130(3):495-500. PubMed ID: 22607887
    [Abstract] [Full Text] [Related]

  • 3. C-reactive protein, prothrombotic imbalance and endothelial dysfunction in acute coronary syndromes without ST elevation.
    Apetrei E, Ciobanu-Jurcuţ R, Rugină M, Gavrilă A, Uscătescu V.
    Rom J Intern Med; 2004 Sep; 42(1):95-102. PubMed ID: 15529598
    [Abstract] [Full Text] [Related]

  • 4. Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality.
    Collet JP, Montalescot G, Vicaut E, Ankri A, Walylo F, Lesty C, Choussat R, Beygui F, Borentain M, Vignolles N, Thomas D.
    Circulation; 2003 Jul 29; 108(4):391-4. PubMed ID: 12860898
    [Abstract] [Full Text] [Related]

  • 5. Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models.
    Di Stefano R, Di Bello V, Barsotti MC, Grigoratos C, Armani C, Dell'Omodarme M, Carpi A, Balbarini A.
    Biomed Pharmacother; 2009 Dec 29; 63(10):773-80. PubMed ID: 19906505
    [Abstract] [Full Text] [Related]

  • 6. [Relation of an increase of von Willebrand factor in the blood, acute myocardial infarction, unstable angina and coronary thrombosis].
    Mossard JM, Wiesel ML, Cazenave JP, Grunebaum L, Drawin T, Kieny JR, Roul G, Bareiss P, Sacrez A.
    Arch Mal Coeur Vaiss; 1989 Nov 29; 82(11):1813-8. PubMed ID: 2514633
    [Abstract] [Full Text] [Related]

  • 7. Plasma thrombomodulin activity, tissue factor activity and high levels of circulating procoagulant phospholipid as prognostic factors for acute myocardial infarction.
    Van Dreden P, Rousseau A, Savoure A, Lenormand B, Fontaine S, Vasse M.
    Blood Coagul Fibrinolysis; 2009 Dec 29; 20(8):635-41. PubMed ID: 19809306
    [Abstract] [Full Text] [Related]

  • 8. Early initiation of low-dose atorvastatin treatment after an acute ST-elevated myocardial infarction, decreases inflammatory process and prevents endothelial injury and activation.
    Stefanadi E, Tousoulis D, Antoniades C, Katsi V, Bosinakou E, Vavuranakis E, Triantafyllou G, Marinou K, Tsioufis C, Papageorgiou N, Latsios G, Stefanadis C.
    Int J Cardiol; 2009 Apr 03; 133(2):266-8. PubMed ID: 18187214
    [Abstract] [Full Text] [Related]

  • 9. Comparative short-term prognostic value of hemostatic and inflammatory markers in patients with non-ST elevation acute coronary syndromes.
    Passoni F, Morelli B, Seveso G, Lazzati L, Beria G, Del Rosso G, D'Urbano M, Cafiero F, Mariani G, De Servi S.
    Ital Heart J; 2002 Jan 03; 3(1):28-33. PubMed ID: 11899586
    [Abstract] [Full Text] [Related]

  • 10. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
    Saigo M, Abe S, Ogawa M, Yamashita T, Biro S, Minagoe S, Maruyama I, Tei C.
    Thromb Haemost; 2001 Nov 03; 86(5):1197-203. PubMed ID: 11816707
    [Abstract] [Full Text] [Related]

  • 11. The relationship of plasminogen activator inhibitor-1 levels to the ST deviation pattern of acute myocardial infarction.
    Rott D, Leibowitz D, Finci-Yeheskel Z, Barak V, Chajek-Shaul T, Weiss T, Levin M, Urieli-Shoval S.
    Cardiology; 2009 Nov 03; 112(1):56-9. PubMed ID: 18580060
    [Abstract] [Full Text] [Related]

  • 12. Thrombin activity throughout the acute phase of acute ST-elevation myocardial infarction and the relation to outcome.
    Ulrich-Möckel NV, Riehle M, Vollert J, Heller G, Störk T, Riess H, Müller C, Frei U, Möckel M.
    Biomarkers; 2009 Aug 03; 14(5):311-6. PubMed ID: 19552570
    [Abstract] [Full Text] [Related]

  • 13. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
    Mega JL, Morrow DA, De Lemos JA, Sabatine MS, Murphy SA, Rifai N, Gibson CM, Antman EM, Braunwald E.
    J Am Coll Cardiol; 2004 Jul 21; 44(2):335-9. PubMed ID: 15261928
    [Abstract] [Full Text] [Related]

  • 14. Fibrinolytic status in acute coronary syndromes: evidence of differences in relation to clinical features and pathophysiological pathways.
    Shantsila E, Montoro-García S, Tapp LD, Apostolakis S, Wrigley BJ, Lip GY.
    Thromb Haemost; 2012 Jul 21; 108(1):32-40. PubMed ID: 22538774
    [Abstract] [Full Text] [Related]

  • 15. Association between cardiac troponin T elevation and angioscopic morphology of culprit lesion in patients with non-ST-segment elevation acute coronary syndrome.
    Ohtani T, Ueda Y, Shimizu M, Mizote I, Hirayama A, Hori M, Kodama K.
    Am Heart J; 2005 Aug 21; 150(2):227-33. PubMed ID: 16086923
    [Abstract] [Full Text] [Related]

  • 16. Long-term prognosis of first myocardial infarction according to the electrocardiographic pattern (ST elevation myocardial infarction, non-ST elevation myocardial infarction and non-classified myocardial infarction) and revascularization procedures.
    García-García C, Subirana I, Sala J, Bruguera J, Sanz G, Valle V, Arós F, Fiol M, Molina L, Serra J, Marrugat J, Elosua R.
    Am J Cardiol; 2011 Oct 15; 108(8):1061-7. PubMed ID: 21791326
    [Abstract] [Full Text] [Related]

  • 17. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł, Kasprzak JD, Peruga J, Lipiec P, Drozdz J, Krzemińska-Pakuła M, Smigielski J.
    Kardiol Pol; 2008 Mar 15; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [Abstract] [Full Text] [Related]

  • 18. Changes in plasma C-reactive protein and hemostatic factors prior to and after a first myocardial infarction with a median follow-up time of 8 years.
    Thøgersen AM, Nilsson TK, Weinehall L, Boman K, Eliasson M, Hallmans G, Jansson JH.
    Blood Coagul Fibrinolysis; 2009 Jul 15; 20(5):340-6. PubMed ID: 19357504
    [Abstract] [Full Text] [Related]

  • 19. The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction.
    Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H.
    Thromb Res; 2012 Nov 15; 130(5):765-8. PubMed ID: 22192151
    [Abstract] [Full Text] [Related]

  • 20. [Predictive value of the markers of inflammation in acute coronary syndromes].
    Ben Khalfallah A, Sanaa I, Annabi N, Ousji M, Aloui H, Naffeti S.
    Arch Mal Coeur Vaiss; 2005 Sep 15; 98(9):899-905. PubMed ID: 16231577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.